XML 17 R6.htm IDEA: XBRL DOCUMENT v3.25.1
CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY - USD ($)
$ in Thousands
Total
Common Stock
Additional Paid-In Capital
Accumulated Other Comprehensive Loss
Accumulated Deficit
Beginning balance (in shares) at Dec. 31, 2023   102,824,000      
Beginning balance at Dec. 31, 2023 $ 944,618 $ 103 $ 1,031,627 $ (34,739) $ (52,373)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Repurchases of common stock (in shares)   (2,116,000)      
Repurchase of common stock (114) $ (2) (112)    
Net share settlement of equity awards (in shares)   862,000      
Net share settlement of equity awards (4,293) $ 1 (4,294)    
Share-based compensation expense 30,616   30,616    
Other comprehensive loss (5,933)     (5,933)  
Net loss (1,420)       (1,420)
Ending balance (in shares) at Mar. 31, 2024   101,570,000      
Ending balance at Mar. 31, 2024 963,474 $ 102 1,057,837 (40,672) (53,793)
Beginning balance (in shares) at Dec. 31, 2023   102,824,000      
Beginning balance at Dec. 31, 2023 $ 944,618 $ 103 1,031,627 (34,739) (52,373)
Ending balance (in shares) at Dec. 31, 2024 104,880,048 104,880,000      
Ending balance at Dec. 31, 2024 $ 192,981 $ 105 1,114,550 (32,233) (889,441)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net share settlement of equity awards (in shares)   497,000      
Net share settlement of equity awards (469)   (469)    
Share-based compensation expense 11,657   11,657    
Other comprehensive loss (1,014)     (1,014)  
Net loss $ (17,484)       (17,484)
Ending balance (in shares) at Mar. 31, 2025 105,376,973 105,377,000      
Ending balance at Mar. 31, 2025 $ 185,671 $ 105 $ 1,125,738 $ (33,247) $ (906,925)